CA1223831A
(en)
|
1982-06-23 |
1987-07-07 |
Dean Engelhardt |
Modified nucleotides, methods of preparing and utilizing and compositions containing the same
|
US4948882A
(en)
*
|
1983-02-22 |
1990-08-14 |
Syngene, Inc. |
Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
|
US5821058A
(en)
|
1984-01-16 |
1998-10-13 |
California Institute Of Technology |
Automated DNA sequencing technique
|
USRE43096E1
(en)
|
1984-01-16 |
2012-01-10 |
California Institute Of Technology |
Tagged extendable primers and extension products
|
JPH0692392B2
(ja)
*
|
1986-04-04 |
1994-11-16 |
信彦 勝沼 |
新規プソイドウリジン誘導体
|
US5384241A
(en)
*
|
1987-09-11 |
1995-01-24 |
Enzo Diagnostics, Inc. |
Specific binding assay compound with inhibitive self-quenching characteristics
|
US4965349A
(en)
*
|
1987-12-24 |
1990-10-23 |
Applied Biosystems, Inc. |
Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
|
AU631119B2
(en)
*
|
1988-02-24 |
1992-11-19 |
Institut De Recherches Chimiques Et Biologiques Appliquees (I.R.C.E.B.A.) |
New derivatives of deoxy-2'-uridine substituted in the 5,3' or 5' position by acylated alpha-amino groups, process for obtaining them and drugs containing them
|
US5324831A
(en)
*
|
1988-04-06 |
1994-06-28 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Phosphoramidite reagent for chemical synthesis of modified DNA
|
DE3835772A1
(de)
*
|
1988-10-20 |
1990-04-26 |
Deutsches Krebsforsch |
Tumorhemmende saccharid-konjugate
|
IT1228293B
(it)
*
|
1989-02-06 |
1991-06-07 |
Angeli Inst Spa |
Benzoderivati di composti eterociclici contenenti azoto.
|
KR920701230A
(ko)
*
|
1989-06-05 |
1992-08-11 |
원본미기재 |
엑소뉴클레아제-내성 올리고뉴클레오티드 및 그 제조방법
|
US5256775A
(en)
*
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
US6919211B1
(en)
|
1989-06-07 |
2005-07-19 |
Affymetrix, Inc. |
Polypeptide arrays
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
US6379895B1
(en)
|
1989-06-07 |
2002-04-30 |
Affymetrix, Inc. |
Photolithographic and other means for manufacturing arrays
|
US6551784B2
(en)
|
1989-06-07 |
2003-04-22 |
Affymetrix Inc |
Method of comparing nucleic acid sequences
|
US6309822B1
(en)
|
1989-06-07 |
2001-10-30 |
Affymetrix, Inc. |
Method for comparing copy number of nucleic acid sequences
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US5424186A
(en)
|
1989-06-07 |
1995-06-13 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis
|
US5744101A
(en)
*
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
US6346413B1
(en)
|
1989-06-07 |
2002-02-12 |
Affymetrix, Inc. |
Polymer arrays
|
US6955915B2
(en)
|
1989-06-07 |
2005-10-18 |
Affymetrix, Inc. |
Apparatus comprising polymers
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
US6406844B1
(en)
|
1989-06-07 |
2002-06-18 |
Affymetrix, Inc. |
Very large scale immobilized polymer synthesis
|
US5141813A
(en)
*
|
1989-08-28 |
1992-08-25 |
Clontech Laboratories, Inc. |
Multifunctional controlled pore glass reagent for solid phase oligonucleotide synthesis
|
EP0942000B1
(de)
*
|
1989-10-24 |
2004-06-23 |
Isis Pharmaceuticals, Inc. |
2'-Modifizierte Oligonukleotide
|
US6005087A
(en)
*
|
1995-06-06 |
1999-12-21 |
Isis Pharmaceuticals, Inc. |
2'-modified oligonucleotides
|
US6506558B1
(en)
|
1990-03-07 |
2003-01-14 |
Affymetrix Inc. |
Very large scale immobilized polymer synthesis
|
ATE154246T1
(de)
*
|
1990-07-27 |
1997-06-15 |
Isis Pharmaceuticals Inc |
Nuklease resistente, pyrimidin modifizierte oligonukleotide, die die gen-expression detektieren und modulieren
|
EP0787805A3
(de)
*
|
1990-09-20 |
2004-01-02 |
Amoco Corporation |
Sonde-Zusammensetzungen für Chromosom-Identifizierung und Verfahren
|
EP0834576B1
(de)
|
1990-12-06 |
2002-01-16 |
Affymetrix, Inc. (a Delaware Corporation) |
Detektion von Nukleinsäuresequenzen
|
YU187991A
(sh)
*
|
1990-12-11 |
1994-09-09 |
Hoechst Aktiengesellschaft |
3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba
|
US6124267A
(en)
*
|
1991-02-05 |
2000-09-26 |
Southpac Trust Internationals, Inc. |
O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
|
US6309639B1
(en)
|
1991-02-05 |
2001-10-30 |
The Board Of Regents Of The University Of Oklahoma |
Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
|
US6136601A
(en)
*
|
1991-08-21 |
2000-10-24 |
Epoch Pharmaceuticals, Inc. |
Targeted mutagenesis in living cells using modified oligonucleotides
|
US6468740B1
(en)
|
1992-11-05 |
2002-10-22 |
Affymetrix, Inc. |
Cyclic and substituted immobilized molecular synthesis
|
US6943034B1
(en)
|
1991-11-22 |
2005-09-13 |
Affymetrix, Inc. |
Combinatorial strategies for polymer synthesis
|
CA2124087C
(en)
*
|
1991-11-22 |
2002-10-01 |
James L. Winkler |
Combinatorial strategies for polymer synthesis
|
US6864101B1
(en)
|
1991-11-22 |
2005-03-08 |
Affymetrix, Inc. |
Combinatorial strategies for polymer synthesis
|
US5652099A
(en)
|
1992-02-12 |
1997-07-29 |
Conrad; Michael J. |
Probes comprising fluorescent nucleosides and uses thereof
|
EP0628051B1
(de)
*
|
1992-02-12 |
2003-07-02 |
Chromagen, Inc. |
Verwendungen von fluoreszierenden n-nukleosiden und dessen analogen
|
TW323284B
(de)
*
|
1992-03-23 |
1997-12-21 |
Novartis Ag |
|
US6235886B1
(en)
*
|
1993-09-03 |
2001-05-22 |
Isis Pharmaceuticals, Inc. |
Methods of synthesis and use
|
WO1994006815A1
(en)
|
1992-09-11 |
1994-03-31 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide and nucleotide amine analogs, methods of synthesis and use
|
US5695752A
(en)
*
|
1992-09-11 |
1997-12-09 |
The Regents Of The University Of California |
Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
|
US6194144B1
(en)
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
CA2114355A1
(en)
*
|
1993-01-29 |
1994-07-30 |
Hidehiko Furukawa |
Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
|
US5412123A
(en)
*
|
1993-02-08 |
1995-05-02 |
Glycomed Incorporated |
Anthraquinone and anthracene derivatives as inhibitors of the cell-adhesion molecules of the immune system
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
US5789385A
(en)
*
|
1993-06-16 |
1998-08-04 |
Glycomed Incorporated |
Sialyl Lewisx mimetics containing phenyl backbones
|
US5837689A
(en)
*
|
1993-06-16 |
1998-11-17 |
Glycomed Incorporated |
Sialyl lewis-x mimetics containing naphthyl backbones
|
US5658880A
(en)
*
|
1993-06-16 |
1997-08-19 |
Glycomed Incorporated |
Sialic acid/fucose based medicaments
|
US5508387A
(en)
*
|
1993-08-04 |
1996-04-16 |
Glycomed Incorporated |
Selectin binding glycopeptides
|
AU8088694A
(en)
*
|
1993-10-27 |
1995-05-22 |
Ribozyme Pharmaceuticals, Inc. |
2'-amido and 2'-peptido modified oligonucleotides
|
US5591578A
(en)
*
|
1993-12-10 |
1997-01-07 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US5952172A
(en)
|
1993-12-10 |
1999-09-14 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US6071699A
(en)
*
|
1996-06-07 |
2000-06-06 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US5824473A
(en)
*
|
1993-12-10 |
1998-10-20 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US5575071A
(en)
*
|
1994-01-19 |
1996-11-19 |
Porter-Cable Corporation |
Toolless quickchange blade clamp for reciprocating saws
|
US7323298B1
(en)
|
1994-06-17 |
2008-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarray for determining the relative abundances of polynuceotide sequences
|
US5620850A
(en)
|
1994-09-26 |
1997-04-15 |
President And Fellows Of Harvard College |
Molecular recognition at surfaces derivatized with self-assembled monolayers
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
FR2732344B1
(fr)
*
|
1995-04-03 |
1997-06-20 |
Genset Sa |
Oligonucleotides a liaison covalente transversale, procede de preparation et synthon utile dans le procede
|
WO1997014706A1
(en)
|
1995-10-19 |
1997-04-24 |
Nexstar Pharmaceuticals, Inc. |
Method for solution phase synthesis of oligonucleotides
|
US5705621A
(en)
*
|
1995-11-17 |
1998-01-06 |
Isis Pharmaceuticals, Inc. |
Oligomeric phosphite, phosphodiester, Phosphorothioate and phosphorodithioate compounds and intermediates for preparing same
|
EP0880598A4
(de)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Verfahren zur analyse von nukleinsäure
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
US6444423B1
(en)
|
1996-06-07 |
2002-09-03 |
Molecular Dynamics, Inc. |
Nucleosides comprising polydentate ligands
|
WO1998003532A1
(en)
*
|
1996-07-24 |
1998-01-29 |
Hanna Michelle M |
Base-protected nucleotide analogs with protected thiol groups
|
ES2241042T3
(es)
|
1996-10-11 |
2005-10-16 |
The Regents Of The University Of California |
Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
|
US7381525B1
(en)
|
1997-03-07 |
2008-06-03 |
Clinical Micro Sensors, Inc. |
AC/DC voltage apparatus for detection of nucleic acids
|
US7160678B1
(en)
|
1996-11-05 |
2007-01-09 |
Clinical Micro Sensors, Inc. |
Compositions for the electronic detection of analytes utilizing monolayers
|
US7014992B1
(en)
*
|
1996-11-05 |
2006-03-21 |
Clinical Micro Sensors, Inc. |
Conductive oligomers attached to electrodes and nucleoside analogs
|
US7045285B1
(en)
|
1996-11-05 |
2006-05-16 |
Clinical Micro Sensors, Inc. |
Electronic transfer moieties attached to peptide nucleic acids
|
US6096273A
(en)
|
1996-11-05 |
2000-08-01 |
Clinical Micro Sensors |
Electrodes linked via conductive oligomers to nucleic acids
|
US7393645B2
(en)
*
|
1996-11-05 |
2008-07-01 |
Clinical Micro Sensors, Inc. |
Compositions for the electronic detection of analytes utilizing monolayers
|
WO1998055492A1
(fr)
*
|
1997-06-03 |
1998-12-10 |
Ajinomoto Co., Inc. |
Procede de production de v-28-3m antifongique
|
EP2085090A3
(de)
|
1997-06-06 |
2012-05-02 |
The Regents of the University of California |
Inhibitoren von immunstimulatorischen DNA Sequenz Aktivität
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US20040006034A1
(en)
*
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6013459A
(en)
*
|
1997-06-12 |
2000-01-11 |
Clinical Micro Sensors, Inc. |
Detection of analytes using reorganization energy
|
DE19741084A1
(de)
*
|
1997-09-18 |
1999-03-25 |
Knoell Hans Forschung Ev |
Hochaffine Nukleinsäuremoleküle mit funktionellen Gruppen zur spezifischen Erkennung von Zielmolekülen, ihre Herstellung und Verwendung
|
EP1051517A2
(de)
|
1998-01-27 |
2000-11-15 |
Clinical Micro Sensors, Inc. |
Amplifizierung von nukleinsäuren mit elektronischer erkennung
|
US6686150B1
(en)
|
1998-01-27 |
2004-02-03 |
Clinical Micro Sensors, Inc. |
Amplification of nucleic acids with electronic detection
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6761816B1
(en)
*
|
1998-06-23 |
2004-07-13 |
Clinical Micro Systems, Inc. |
Printed circuit boards with monolayers and capture ligands
|
US7087148B1
(en)
|
1998-06-23 |
2006-08-08 |
Clinical Micro Sensors, Inc. |
Binding acceleration techniques for the detection of analytes
|
US6290839B1
(en)
|
1998-06-23 |
2001-09-18 |
Clinical Micro Sensors, Inc. |
Systems for electrophoretic transport and detection of analytes
|
WO2000009753A1
(en)
*
|
1998-08-11 |
2000-02-24 |
Caliper Technologies Corp. |
Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes
|
US6447724B1
(en)
|
1998-08-11 |
2002-09-10 |
Caliper Technologies Corp. |
DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
|
US6716394B2
(en)
|
1998-08-11 |
2004-04-06 |
Caliper Technologies Corp. |
DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
|
US6288221B1
(en)
|
1998-08-20 |
2001-09-11 |
Duke University |
Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction
|
US6740518B1
(en)
|
1998-09-17 |
2004-05-25 |
Clinical Micro Sensors, Inc. |
Signal detection techniques for the detection of analytes
|
AU766492B2
(en)
*
|
1998-09-18 |
2003-10-16 |
Dynavax Technologies Corporation |
Methods of treating IgE-associated disorders and compositions for use therein
|
WO2000024941A1
(en)
|
1998-10-27 |
2000-05-04 |
Clinical Micro Sensors, Inc. |
Detection of target analytes using particles and electrodes
|
US6545264B1
(en)
|
1998-10-30 |
2003-04-08 |
Affymetrix, Inc. |
Systems and methods for high performance scanning
|
US6184347B1
(en)
|
1998-11-19 |
2001-02-06 |
Agilent Technologies Inc. |
Minimization of blooming in high-density arrays by using reactive wash reagents
|
US6264891B1
(en)
*
|
1998-12-22 |
2001-07-24 |
Eos Biotechnology, Inc. |
Apparatus and method for concurrent chemical synthesis
|
US6833267B1
(en)
*
|
1998-12-30 |
2004-12-21 |
Clinical Micro Sensors, Inc. |
Tissue collection devices containing biosensors
|
WO2000056749A1
(en)
|
1999-03-24 |
2000-09-28 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
N-acylphosphoramidites and their use in oligonucleotide synthesis
|
US7312087B2
(en)
|
2000-01-11 |
2007-12-25 |
Clinical Micro Sensors, Inc. |
Devices and methods for biochip multiplexing
|
US20020177135A1
(en)
*
|
1999-07-27 |
2002-11-28 |
Doung Hau H. |
Devices and methods for biochip multiplexing
|
US6942771B1
(en)
|
1999-04-21 |
2005-09-13 |
Clinical Micro Sensors, Inc. |
Microfluidic systems in the electrochemical detection of target analytes
|
EP1218541B1
(de)
|
1999-07-26 |
2008-12-10 |
Clinical Micro Sensors, Inc. |
Nukelinsäuresequenzbestimmung mittels elektronischem nachweis
|
WO2001012223A2
(en)
|
1999-08-19 |
2001-02-22 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
US6593088B1
(en)
*
|
1999-08-27 |
2003-07-15 |
Japan Science And Technology Corporation |
Reversible photocoupling nucleic acid and phosphoroamidite
|
US6395142B1
(en)
*
|
1999-10-14 |
2002-05-28 |
Chemcycles, Inc. |
Method and apparatus for purifying low grade acetonitrile and other constituents from hazardous waste
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
US20010046967A1
(en)
*
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
US7157437B2
(en)
*
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US20020028784A1
(en)
*
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US20020107212A1
(en)
*
|
2000-03-10 |
2002-08-08 |
Nest Gary Van |
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US6753143B2
(en)
|
2000-05-01 |
2004-06-22 |
Clinical Micro Sensors, Inc. |
Target analyte detection using asymmetrical self-assembled monolayers
|
JP4382265B2
(ja)
*
|
2000-07-12 |
2009-12-09 |
日本電気株式会社 |
酸化シリコン膜の形成方法及びその形成装置
|
US6397150B1
(en)
|
2000-07-27 |
2002-05-28 |
Visible Genetics Inc. |
Method and apparatus for sequencing of DNA using an internal calibrant
|
CA2430691A1
(en)
*
|
2000-12-27 |
2002-07-04 |
Dynavax Technologies Corporation |
Immunomodulatory polynucleotides and methods of using the same
|
US6541626B2
(en)
*
|
2001-04-17 |
2003-04-01 |
Isis Pharmaceuticals, Inc. |
Process for selective N-acylation of purine nucleosides
|
PT1404873E
(pt)
|
2001-06-21 |
2013-07-30 |
Dynavax Tech Corp |
Compostos de imunomodulação quiméricos e métodos de utilização dos mesmos
|
US7785610B2
(en)
*
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
JP4607452B2
(ja)
*
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
US7222059B2
(en)
*
|
2001-11-15 |
2007-05-22 |
Siemens Medical Solutions Diagnostics |
Electrophoretic trace simulator
|
US7355037B2
(en)
*
|
2001-12-03 |
2008-04-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thermolabile hydroxyl protecting groups and methods of use
|
JP2005515780A
(ja)
|
2002-02-01 |
2005-06-02 |
セクイター インコーポレイテッド |
二本鎖オリゴヌクレオチド
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP1572902B1
(de)
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HOCHWIRKSAME siRNAS ZUR REDUZIERUNG DER EXPRESSION VON ZIELGENEN
|
FR2840611B1
(fr)
*
|
2002-06-06 |
2005-09-09 |
Cis Bio Int |
Entite fluorescente comportant un fluorophore lie de maniere covalente a au moins un oligonucleotide et comportant au moins un groupe fonctionnel et ses utilisations
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
GB2406169B
(en)
*
|
2002-06-12 |
2006-11-01 |
Ambion Inc |
Methods and compositions relating to labeled rna molecules that reduce gene expression
|
US20100075423A1
(en)
*
|
2002-06-12 |
2010-03-25 |
Life Technologies Corporation |
Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
|
WO2004014322A2
(en)
|
2002-08-12 |
2004-02-19 |
Dynavax Technologies Corporation |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
AU2003273336A1
(en)
*
|
2002-09-18 |
2004-04-08 |
Isis Pharmaceuticals, Inc. |
Efficient reduction of target rna's by single- and double-stranded oligomeric compounds
|
US7534872B2
(en)
*
|
2002-09-27 |
2009-05-19 |
Syngen, Inc. |
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis
|
EP1578765A4
(de)
|
2002-11-05 |
2008-04-23 |
Isis Pharmaceuticals Inc |
Oligomere verbindungen,die zuckerersatzstoffe enthalten, und zusammensetzung zur verwendung in dergenmodulation
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
CN100546998C
(zh)
|
2002-12-23 |
2009-10-07 |
戴纳伐克斯技术股份有限公司 |
免疫刺激序列寡核苷酸和使用方法
|
AU2003302743B2
(en)
*
|
2002-12-23 |
2008-09-04 |
Dynavax Technologies Corporation |
Branched immunomodulatory compounds and methods of using the same
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
WO2005107404A2
(en)
*
|
2004-05-03 |
2005-11-17 |
The Penn State Research Foundation |
Methods and systems for nanoparticle enhancement of signals
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
AU2005252662B2
(en)
*
|
2004-06-03 |
2011-08-18 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
US20080286880A1
(en)
*
|
2004-07-07 |
2008-11-20 |
The Penn State Research Foundation |
Methods and Systems for Nanoparticle Enhancement of Signals
|
WO2006033730A2
(en)
*
|
2004-08-20 |
2006-03-30 |
Dharmacon, Inc. |
Novel polynucleotide synthesis labeling chemistry
|
ES2385657T3
(es)
*
|
2004-09-01 |
2012-07-27 |
Dynavax Technologies Corporation |
Métodos y composiciones para la inhibición de respuestas inmunes innatas y autoinmunidad
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
EP2322616A1
(de)
|
2004-11-12 |
2011-05-18 |
Asuragen, Inc. |
Verfahren und Zusammensetzungen, die miRNAs und miRNA-inhibitorischen Molekülen verbunden sind
|
US9809824B2
(en)
*
|
2004-12-13 |
2017-11-07 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
AU2005316503A1
(en)
*
|
2004-12-17 |
2006-06-22 |
Dynavax Technologies Corporation |
Methods and compositions for induction or promotion of immune tolerance
|
US20060142228A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
US20090286696A1
(en)
*
|
2005-02-04 |
2009-11-19 |
University Of Wollongong |
Double-Stranded Olidonucleotides and Uses Therefor
|
CN104857512A
(zh)
*
|
2006-11-09 |
2015-08-26 |
戴纳瓦克斯技术公司 |
使用免疫刺激性寡核苷酸进行长期的疾病修饰
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
AU2008317261B2
(en)
*
|
2007-10-26 |
2015-04-09 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
JP5115312B2
(ja)
*
|
2008-05-02 |
2013-01-09 |
ソニー株式会社 |
核酸分離用担体の製造方法、及び核酸分離用担体とマイクロ流路系、並びに核酸分離方法と核酸分離装置
|
WO2009140626A2
(en)
|
2008-05-15 |
2009-11-19 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
CA2795054A1
(en)
|
2010-04-01 |
2011-10-06 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
CN103153346A
(zh)
|
2010-06-16 |
2013-06-12 |
戴纳瓦克斯技术公司 |
使用tlr7和/或tlr9抑制剂的治疗方法
|
WO2012110824A1
(en)
|
2011-02-18 |
2012-08-23 |
Astrazeneca Ab |
Binding agents with specificity for a nucleic acid modification
|
EP2691409B1
(de)
|
2011-03-31 |
2018-02-21 |
Idenix Pharmaceuticals LLC. |
Verbindungen und zusammensetzungen zur behandlung von virusinfektionen
|
US9228184B2
(en)
|
2012-09-29 |
2016-01-05 |
Dynavax Technologies Corporation |
Human toll-like receptor inhibitors and methods of use thereof
|
JP6358955B2
(ja)
|
2012-10-31 |
2018-07-18 |
武田薬品工業株式会社 |
新規修飾核酸
|
AU2014306271A1
(en)
|
2013-08-08 |
2016-03-24 |
The Scripps Research Institute |
A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
|
TWI638047B
(zh)
|
2014-04-09 |
2018-10-11 |
史基普研究協會 |
藉由核酸三磷酸酯轉運子將非天然或經修飾的核苷三磷酸酯輸入至細胞中
|
US11761007B2
(en)
|
2015-12-18 |
2023-09-19 |
The Scripps Research Institute |
Production of unnatural nucleotides using a CRISPR/Cas9 system
|
EP3475295B1
(de)
|
2016-06-24 |
2022-08-10 |
The Scripps Research Institute |
Neuartiger nukleosid-triphosphat-transporter und verwendungen davon
|
AU2018300069A1
(en)
|
2017-07-11 |
2020-02-27 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
TWI757528B
(zh)
|
2017-08-03 |
2022-03-11 |
美商欣爍克斯公司 |
用於增生及感染性疾病治療之細胞激素結合物
|
KR20200127207A
(ko)
|
2018-02-26 |
2020-11-10 |
신톡스, 인크. |
Il-15 접합체 및 이의 용도
|
AU2020218203A1
(en)
|
2019-02-06 |
2021-08-26 |
Synthorx, Inc. |
IL-2 conjugates and methods of use thereof
|
TW202113078A
(zh)
|
2019-06-14 |
2021-04-01 |
美商史基普研究協會 |
於半合成生物體中複製、轉錄及轉譯之試劑及方法
|
CN114555128A
(zh)
|
2019-08-15 |
2022-05-27 |
新索思股份有限公司 |
采用il-2缀合物的免疫肿瘤学组合疗法
|
MX2022002053A
(es)
|
2019-08-23 |
2022-03-17 |
Synthorx Inc |
Conjugados de il-15 y sus usos.
|
KR20220061158A
(ko)
|
2019-09-10 |
2022-05-12 |
신톡스, 인크. |
자가면역질환을 치료하기 위한 il-2 접합체 및 사용 방법
|
TW202131952A
(zh)
|
2019-11-04 |
2021-09-01 |
美商欣爍克斯公司 |
介白素10接合物及其用途
|
IL299074A
(en)
|
2020-06-25 |
2023-02-01 |
Synthorx Inc |
Immuno-oncology therapeutic combination with IL-2 and anti-AGFR antibody conjugates
|
KR20230084204A
(ko)
|
2020-10-09 |
2023-06-12 |
신톡스, 인크. |
Il-2 콘쥬게이트를 사용한 면역 종양학 치료법
|
CA3194859A1
(en)
|
2020-10-09 |
2022-04-14 |
Carolina E. CAFFARO |
Immuno oncology combination therapy with il-2 conjugates and pembrolizumab
|
WO2022174101A1
(en)
|
2021-02-12 |
2022-08-18 |
Synthorx, Inc. |
Skin cancer combination therapy with il-2 conjugates and cemiplimab
|
TW202302148A
(zh)
|
2021-02-12 |
2023-01-16 |
美商欣爍克斯公司 |
使用il-2接合物和抗pd-1抗體或其抗原結合片段的肺癌組合療法
|
TW202313679A
(zh)
|
2021-06-03 |
2023-04-01 |
美商欣爍克斯公司 |
包含il-2接合物及pd-1拮抗劑之頭頸癌組合療法
|
WO2023122573A1
(en)
|
2021-12-20 |
2023-06-29 |
Synthorx, Inc. |
Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
|
WO2023122750A1
(en)
|
2021-12-23 |
2023-06-29 |
Synthorx, Inc. |
Cancer combination therapy with il-2 conjugates and cetuximab
|